Becton Dickinson Reaches New 52-Week High (BDX)
NEW YORK (
) --
(NYSE:
) hit a new 52-week high Thursday as it is currently trading at $102.75, above its previous 52-week high of $102.72 with 95,427 shares traded as of 10:36 a.m. ET. Average volume has been 948,600 shares over the past 30 days.
Becton Dickinson has a market cap of $19.79 billion and is part of the health care sector and health services industry. Shares are up 30.4% year to date as of the close of trading on Wednesday.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
Becton Dickinson
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
Becton Dickinson Ratings Report
.
See all
52-week high stocks
or get investment ideas from our
.
.
null